Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DVD-R for Relapsed/Refractory Multiple Myeloma
NCT01160484Phase 2Completed
- Sponsor
- ONCOtherapeutics
- Start
- Sep 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in multiple myeloma (MM), sponsored by ONCOtherapeutics. Started Sep 2009; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01160484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01160484.